Category Archives: Tms

Mar 23, 2020 (Thomson StreetEvents) -- Edited Transcript of Brainsway Ltd earnings conference call or presentation Monday, March 23, 2020 at 12:30:00pm GMT

* Christopher R. von Jako

Brainsway Ltd. - President & CEO

Brainsway Ltd. - CFO & COO

Raymond James & Associates, Inc., Research Division - Senior Medical Supplies and Devices Analyst

Ladenburg Thalmann & Co. Inc., Research Division - MD of Equity Research

Oppenheimer & Co. Inc., Research Division - MD and Senior Analyst

* Robert A. Yedid

Ladies and gentlemen, thank you for standing by, and welcome to today's BrainsWay reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights Conference Call. (Operator Instructions) I must advise you that this conference is being recorded today, Monday, the 23rd of March 2020.

I would now like to hand the conference over to your first speaker today, Bob Yedid. Thank you. Please go ahead, sir.

Robert A. Yedid, LifeSci Advisors, LLC - MD [2]

Good morning, and afternoon to everyone. I'd like to welcome all of you to BrainsWay Ltd.'s Fourth Quarter and Full Year Conference Call. With us today are Chris von Jako, Chief Executive Officer; and Hadar Levy, Chief Financial Officer. They will provide an overview of the company's business activities and developments for the fourth quarter. We will then open up the call for questions and answers.

Before I turn over the call to Chris and Hadar, I'd like to remind you that this conference call, including both management's prepared remarks and the question-and-answer session, may contain projections and other forward-looking statements regarding future events or the future performance of BrainsWay, including, but not limited to, any statements relating to commercial plans or activities, financial projections, clinical studies, R&D plans and/or anticipated time lines. When used in this call, the words anticipate, could, enable, estimate, intend, expect, believe, potential, will, should, project and similar expressions as they relate to BrainsWay are, as such, a forward-looking statement. These statements are only predictions, and BrainsWay cannot guarantee that they will, in fact, occur. BrainsWay does not assume any obligation to update that information. Investors are cautioned that all forward-looking statements involve risks and uncertainties that may cause actual results to differ from those anticipated by BrainsWay at this time. Additional risks concerning factors that may cause actual events, results or achievements to materially differ from those contained in the forward-looking statements can be found in the company's registration statement on form F1 and its other filings with the Securities and Exchange Commission.

Today, the company issued a press release announcing the financial results for Q4 and full year 2019. So participants in this call who may have not already done so can find this release on BrainsWay's website as we provide a summary of the results on this call.

With those remarks, I'd like to now -- it's my pleasure to turn the call over to BrainsWay's CEO, Chris von Jako. Chris?

Christopher R. von Jako, Brainsway Ltd. - President & CEO [3]

--------------------------------------------------------------------------------

Thank you, Bob, and welcome, everyone, to BrainsWay's Fourth Quarter and Full Year 2019 Earnings Call. As you know, I stepped into the role of CEO in January of this year, although I had the opportunity to introduce myself on our third quarter earnings call last November.

Today, I'd like to provide you with an overview of how I spent my first 80 days as CEO as well as my initial impressions of BrainsWay. I'll turn the call over to Hadar Levy, our Chief Financial Officer, to discuss our financial results after. I'll then conclude by highlighting our R&D efforts and clinical trial activities as well as other key focus areas for 2020.

With that, let me begin by briefly reviewing my first few months as CEO. Over this period, I've spent a significant amount of time listening to our key stakeholders, including customers, key opinion leaders, our sales and development teams and investors. Quite simply, these interactions have left me even more energized and optimistic about our future potential than it already was. We have developed some great relationships with our current customer base, and we have a clear opportunity to grow with these existing customers and expand with new customers.

From a technology standpoint, we have a safe and effective product that has well-differentiated technology to serve multiple very large markets of underserved patients. Importantly, we are not only focused on the growth of our technology for major depressive disorder, or MDD, which itself represents a target market of over 17 million patients in the U.S., but also for obsessive compulsive disorder, or OCD, which affects over 2 million patients in the U.S. alone. Moreover, we have a robust pipeline of other psychiatric, neurological and addiction disorders.

I would now like to briefly discuss the coronavirus, which is causing meaningful complications to daily life and business operations for us all. Our primary concern is for the health and safety of our customers, their patients, our employees and their families. We are following all CDC guidelines to help combat this global health pandemic. Of course, these are challenging times, and we recognize the importance of patients continuing to receive their Deep TMS treatment. Therefore, BrainsWay remains fully operational and dedicated to serving customers to the best of our ability.

With investors, because travel has been severely limited, we are now operating in a virtual world. With that said, we have been aggressively telling our story to investors and are continuing to build relationships that will serve us well. In fact, I recently conducted conference calls with investors around 2 large health care investment bank-sponsored meetings. We will continue to conduct virtual meetings with investors over the coming months in order to share our company's differentiated technology and value proposition.

As I mentioned, our Deep TMS system has demonstrated clinical efficacy in MDD and OCD and is well tolerated. Of significance, our FDA clearance in both MDD and OCD provide us with substantial competitive advantage in the marketplace. Our customers can treat both sets of patients with our platform technology, while other TMS technologies can only treat MDD patients.

With this, we have a unique opportunity to create a medical device leader in the noninvasive brain disorder treatment space. We have a proven track record of sales execution, continue to focus on the science to improve our technology and conduct clinical trials to potentially expand into new indications. In addition, we have a strong balance sheet with the necessary resources to support our growth plans as well as a talented and dedicated employee base.

We delivered very solid results in the fourth quarter and full year 2019. Moreover, I'm proud to report that we installed our 500th system in the fourth quarter. We now have treated over 50,000 patients and delivered over 1 million treatments with our Deep TMS system. We also delivered positive results in multiple clinical studies, which I will discuss further following Hadar's review of the financial results.

Before I turn the call over to Hadar, I'd like to briefly discuss the importance of what we do here at BrainsWay every day. When people think of the costliest major health conditions, diseases such as cancer, diabetes and heart disease always come to mind. However, the conditions that top the list are diseases that unfortunately also have had a long stigma associated with it, mental health disorders.

Today's most common treatment options are various forms of psychiatric medications and therapy. More recently added are -- and far less common are neurostimulation devices that are implanted into the brain. For this reason, I could hear the excitement and the voices of many psychiatrists I have talked to about BrainsWay's noninvasive Deep TMS. It is clear to me that they view Deep TMS as a potential game-changing option for many people suffering from mental health disorders.

With that, I will now pass the call over to Hadar for his review of our financial results.

--------------------------------------------------------------------------------

Hadar Levy, Brainsway Ltd. - CFO & COO [4]

--------------------------------------------------------------------------------

Thank you, Chris. We are very pleased with our strong performance in the fourth quarter and throughout the year in 2019. Our positive results reflect the continued increase in demand for our Deep TMS system.

Let's turn to our key results for the fourth quarter of 2019. We generated a quarterly record revenue of $6.3 million, an increase of 32% over the fourth quarter of 2018. Our recurring revenue was $3.5 million, an increase of 25% year-over-year. This recurring revenue demonstrates the benefit of the BrainsWay business model, in which a significant portion of our Deep TMS customers entered into a lease arrangement that generates recurring revenue over a 3- to 4-year period and provides greater predictability of our future growth.

Since year-end 2018, BrainsWay installed base has increased by 147 systems, reaching a total of 530 Deep TMS systems as of December 31, 2019, and reflecting a quarter-over-quarter increase of 42 systems.

At year-end 2019, the company had shipped 173 OCD coils as add-on helmets to certain of BrainsWay new and existing systems since marketing clearance was obtained in August 2018. You will recall that in the third quarter, demands for additional OCD coils outpaced our ability to fully satisfy all the orders we received. As we expected, this additional demand was fulfilled in the fourth quarter. I should add that we continue to work to obtain reimbursement in the U.S. for our OCD treatment.

While I will review our financial results in greater detail shortly, you will note an increase in our operating expenses year-over-year in the fourth quarter and for the full year of 2019. This is primarily due to the investments we are making in the future growth of our business, one of the key objectives we set when we successfully completed our U.S. IPO last year.

We added a net of 6 new sales professional in 2019, ending the year with 18 total sales professional in the U.S. We intend to add approximately 6 new sales professional in 2020.

As a reminder, a key part of our strategy is that we intend to execute upon our growth strategy by continuing to invest in our sales and marketing activities globally. While we are attuned to the short-term challenges in this difficult period, we remain confident that this investment will help drive long-term growth.

Now I would like to provide a detailed review of our financial performance in the fourth quarter of 2019. I discussed our strong top line results earlier, so I will now review our profitability metrics. Gross profit for the fourth quarter of 2019 was $4.9 million, an increase of 32% from $3.7 million during the prior year period. Gross margin for the fourth quarter of 2019 was 77%, the same as the prior year period. Research and development expenses for the quarter were $1.8 million, similar to the same period in 2018 and primarily consisted of the continued development of our Deep TMS technology, including finalizing the smoking cessation study and conducting clinical trials for treatment of PTSD and other disorders. Sales and marketing expenses for the fourth quarter of 2019 were $3.6 million, an increase of $1.1 million over the prior year. The increase was mainly driven by enhanced marketing activities for MDD and OCD, and a larger number of sales professional as compared to 2018. General and administrative expenses for the quarter were $1.4 million as compared to $1.1 million in the prior year period. This increase was driven by additional costs associated with our current status as a public company in the U.S. and an increase in noncash provision for doubtful debt. Total operating expenses for the fourth quarter totaled $6.8 million compared to $5.4 million a year ago. For the fourth quarter ended December 31, 2019, we incurred a net loss of $2.3 million compared to $2.1 million recorded in the fourth quarter of 2018.

For the full year of 2019, we are proud of our strong growth in revenue and systems. In 2019, we reported revenue of $23.1 million, an increase of 41% over our revenue of $16.4 million in 2018. The recurring revenue was $13.3 million, an increase of 38% over 2018. In 2019, we incurred a net loss of $10.4 million compared to $6.5 million in the prior year as we increased our sales and marketing effort and incurred higher expenses as a public company.

Moving to the balance sheet. We ended 2019 with a cash and cash equivalent of $21.9 million compared to $23.7 million as of September 30, 2019. Cash used during the fourth quarter was in line with our expectations. We believe that our strong balance sheet will allow us, at appropriate time, to expand our sales and marketing efforts further to drive additional adoption of the Deep TMS system, continue to invest in R&D in order to explore new potential indications.

With that, I'd like to turn the call over to Chris for some further thoughts before we open up the call for questions and answer. Chris?

--------------------------------------------------------------------------------

Christopher R. von Jako, Brainsway Ltd. - President & CEO [5]

--------------------------------------------------------------------------------

Thanks, Hadar. I would like to discuss our ongoing efforts to ramp up our R&D efforts. We have a robust clinical pipeline, including studies in multiple potential indications for Deep TMS beyond our FDA-cleared treatments for MDD and OCD. During the fourth quarter, we announced final positive results from our multicenter smoking cessation study. The data from this large randomized pivotal study demonstrated that our Deep TMS can potentially play an important role in helping cigarette smokers who seek to quit. Within the next few weeks, we intend to submit a 510(k) application to the FDA for this expanded indication. We expect a regulatory decision from the FDA and our submission within the next 12 months.

Importantly, our preparations for this new and large potential indication are currently underway. Approximately 38 million U.S. adults smoke cigarettes and 480,000 die from smoking each year. So this is obviously a serious public health issue. There are limited treatment options that exist today in this area, and Deep TMS may be able to address the significant unmet medical need.

Last month, we also announced positive results from our feasibility study of Deep TMS in the treatment of adults with ADHD. The results showed a statistically significant improvement in patient-reported assessments of inattention, together with a significant increase in activity that was observed within the dorsolateral prefrontal cortex, a part of the brain previously shown to have reduced activity in adults with ADHD. These patients currently take a significant amount of medications, some of which carry substantial side effects. And the compelling results of the study indicate that Deep TMS to potentially provide a nonpharmaceutical treatment option. We are currently evaluating the next steps further -- for further research into this area.

We also recently announced the interim results in our PTSD study. Unfortunately, Deep TMS did not demonstrate sufficient efficacy relative to sham-controlled treatments of PTSD patients. Based on this interim analysis, we will not invest additional resources in order to continue this study. We are, however, performing additional analysis and considering future PTSD studies using alternative parameters.

In opioid abuse, please recall that BrainsWay was selected by the FDA as part of its innovation challenge and received a breakthrough device designation by the FDA. We continue to work internally and with FDA in an effort to initiate this study. We expect to submit an investigational new device application later this year.

Moving on, I would like to highlight the appointment of Avner Lushi to our Board of Directors in February. Avner is an accomplished business leader with close to 20 years of experience in the health care industry as well as in corporate strategy and finance. We look forward to his continued contributions to our business.

Now to summarize. We had an outstanding 41% growth in year-over-year revenues driven by demand for our Deep TMS system. For 2020, we are focused on continued implementation of our growth strategy in target regions in the U.S., our continued efforts to secure reimbursement for OCD, target expansion efforts in OUS regions, improving our overall operational efficiency, executing our planned clinical trials and product development initiatives. We're also increasing our investor relations outreach, and we have a number of investment conferences on the schedule for the year. We will continue to conduct -- continue meeting with -- in-person and virtually with key investment analysts and institutional investors throughout the year. With that, I will now ask the operator to please turn it over for questions. Operator?

================================================================================

Questions and Answers

--------------------------------------------------------------------------------

Operator [1]

--------------------------------------------------------------------------------

(Operator Instructions) We have your first question from the line of Craig Bijou of Cantor Fitzgerald.

--------------------------------------------------------------------------------

Craig William Bijou, Cantor Fitzgerald & Co., Research Division - Research Analyst [2]

--------------------------------------------------------------------------------

Let me start with a couple on COVID-19. So I think you guys do have some visibility into the utilization of your systems. So I wanted to know what kind of impact are you seeing in terms of patients getting treatment? Or what have you been hearing from your customers? And then also maybe just comments on how the -- how COVID-19 has impacted your selling process?

--------------------------------------------------------------------------------

Christopher R. von Jako, Brainsway Ltd. - President & CEO [3]

--------------------------------------------------------------------------------

Craig, thanks a lot. Appreciate the question. Obviously, as I said in our opening statements, obviously, it's impacting all of us. We have reached out to a number of our customers, some of the large and even smaller customers, and we continue to do so. For now, we see that these are essential treatments for these patients, and they're continuing to treat in a majority of our centers, which obviously is great. I think, in general, from what we have heard from a number of our clinics that they're taking, obviously, extra precautions. In addition to that, they're obviously taking additional extra precautions with elderly patients. So with that, you also asked a question, I think, about the sales force. Is that what you did, I'm sorry?

--------------------------------------------------------------------------------

Craig William Bijou, Cantor Fitzgerald & Co., Research Division - Research Analyst [4]

--------------------------------------------------------------------------------

Yes. Just the impact that some of the restrictions are having on your -- the sales process that you guys are seeing?

--------------------------------------------------------------------------------

Christopher R. von Jako, Brainsway Ltd. - President & CEO [5]

--------------------------------------------------------------------------------

Yes. I mean it really is regionally dependent right now, depending on state to state. Our salespeople are still getting out and having meetings, but they're doing quite a bit of also virtual meetings. We've had some really good success over the last 2 weeks of having virtual meetings, and it was really nice to hear from a number of the salespeople about that, those are continuing to happen. So I think we're continuing to push forward in our sales efforts. Obviously, we are hampered by what's happening, but we're continuing to push forward.

--------------------------------------------------------------------------------

Craig William Bijou, Cantor Fitzgerald & Co., Research Division - Research Analyst [6]

--------------------------------------------------------------------------------

Great. That's helpful. On OCD helmets, they were obviously strong in the quarter. Hadar, I think you talked specifically about that. But just remind us how we should think about the timing of contribution -- timing and amount of the contribution? And maybe if you can just expand on your thoughts on the reimbursement timing?

--------------------------------------------------------------------------------

Hadar Levy, Brainsway Ltd. - CFO & COO [7]

--------------------------------------------------------------------------------

So -- obviously, the reimbursement is the key factor for the usage of the coil. We do see some increase in the usage of the OCD. Right now, I would say that it's not really material, but we are very happy to see the increase of usage of the OCD. With respect to the reimbursement, we're still working very hard to get the reimbursement, and we hope to get the reimbursement as soon as possible.

--------------------------------------------------------------------------------

Craig William Bijou, Cantor Fitzgerald & Co., Research Division - Research Analyst [8]

--------------------------------------------------------------------------------

Great. And last one for me. Just how should we think about cash burn in 2020, maybe relative to 2019? And then, I guess, how do you plan on balancing some of your investments to grow the business versus any of the near-term disruption from COVID-19?

--------------------------------------------------------------------------------

Christopher R. von Jako, Brainsway Ltd. - President & CEO [9]

--------------------------------------------------------------------------------

So yes, thank you for the question. Obviously, from our part, we're looking at things from a cash conserve -- we're trying to conserve our cash at the moment in certain places. So we're kind of looking, from an expense side, we had some open headcount, and we're probably pushing those off for a little bit. We're looking at other cash conserving measures as well.

--------------------------------------------------------------------------------

Operator [10]

--------------------------------------------------------------------------------

Your next question comes from the line of Jayson Bedford from Raymond James & Associates, Inc.

--------------------------------------------------------------------------------

Jayson Tyler Bedford, Raymond James & Associates, Inc., Research Division - Senior Medical Supplies and Devices Analyst [11]

--------------------------------------------------------------------------------

Just a few, and not surprisingly, they're COVID-19 related. But as you think about the current U.S. market, are capital decisions still being made? And would you expect to see more interest in the lease model versus the outright sale model?

--------------------------------------------------------------------------------

See the rest here:

Edited Transcript of BRIN.TA earnings conference call or presentation 23-Mar-20 12:30pm GMT - Yahoo Finance

Pokemon GO

The excitement around this is inevitably dampened due to the coronavirus pandemic, but Pokmon GO has made some adjustments to the new A Drive to Investigate research event that should make it easy to do without groups and, ideally, possible to complete without leaving your house. The new Genesect special research went live this morning, and so we can get an idea of all quest steps and rewards thanks to players around the world. If you were wondering whether or not to drop some cash on it, this should help.

Here are the steps:

Part 1

Part 1 rewards: 5 Premium Raid Passes, Pinsir encounter and Genesect Cap

Part 2

Part 2 Rewards: 3 Charged TMs, Skarmory encounter and 3 Super Incubators

Part 3:

Part 4:

Part 4 rewards:3 Fast TMs, Genesect encounter and Glacial Lure Module

Part 5:

Part 5 rewards: Poffin, 10 Genesect Candy and 3 Star Pieces

And there you have it. This will not be the most interesting special research weve ever done, but these are trying times. If you want to play without leaving the house, remember that incense is stronger and cheaper than usual, and that you dont have to do this all right away. Just wait it out, catch what you can and you can accomplish this in no time.

Well have more updates soon, but I wonder what its like over at Niantic right now. As it becomes clear that we may be in this for the long haul, I imagine theyre working on mew ways to make this playable from home that they might never have considered otherwise.

View original post here:

A Drive To Investigate: Full Genesect Special Research Tasks, Steps And Rewards In Pokmon GO - Forbes

Global Transportation Management System Market 2020-2024 The analyst has been monitoring the global transportation management system market and it is poised to grow by USD 1.

New York, March 02, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Transportation Management System (TMS) Market 2020-2024 in North America" - https://www.reportlinker.com/p05868137/?utm_source=GNW 62 bn during 2020-2024, progressing at a CAGR of 9% during the forecast period. Our reports on global transportation management system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current north america market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing need for efficient operations.In addition, integration of technologically advanced solutions is anticipated to boost the growth of the global transportation management system market as well.

Market Segmentation The global transportation management system market is segmented as below: Solution: o Cloud-based

o On-premises

Geographic Segmentation: o The US

o Canada

o Mexico

Key Trends for global transportation management system market growth This study identifies integration of technologically advanced solutions as the prime reasons driving the global transportation management system market growth during the next few years.

Prominent vendors in global transportation management system market We provide a detailed analysis of around 25 vendors operating in the global transportation management system market, including some of the vendors such as American Software Inc., BluJay Solutions Ltd., E2open LLC, Epicor Software Corp., JDA Software Group Inc., Manhattan Associates Inc., Oracle Corp., SAP SE, The Descartes Systems Group Inc. and WiseTech Global Ltd. . The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.Read the full report: https://www.reportlinker.com/p05868137/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

See the article here:

The Transportation Management System (TMS) MARKET is expected to grow by USD 1.62 bn during 2020-2024, progressing at a CAGR of 9% during the forecast...

Trainers, attention! The GO Battle League preseason is coming to an end, and Niantic has just announced that Season 1 starts this month on Friday, March 13, 2020, at 1:00 p.m. PDT (GMT 7)!

Niantic has prepared a metric ton of events, rewards and challenges in the period leading up to the start of Season 1, all of which weve collected and broken down in this article. New shiny Pokmon and Elite Fast and Charged TMs are on their way as well!

Note for all events mentioned in this post: In-game events for may vary in the following areas until further notice. Players in these areas can stay tuned to official Niantic and GO Hub channels for updates.

As a thank you for participating in Preseason, Trainers who achieved rank 4 or higher will receive a Premium Battle Pass as part of their end-of-preseason rewards.

To celebrate the end of the preseason, from today, Thursday, March 5, 2020, at 1:00 p.m. PST (GMT 8) to Friday, March 13, 2020, at 1:00 p.m. PDT (GMT 7), all three leagues will be available to play in the GO Battle League!

For a limited time, Darkrai, Altered Forme Giratina, and Thundurus will be coming to the GO Battle League as rare reward encounters, starting at rank 4! Darkrai and Altered Forme Giratina especially can be powerful additions to your Ultra League and Master League teams, so be sure to catch them if you can!

Leading up to and at the beginning of Season 1, look forward to the following GO Battle Leaguethemed events to help you catch strong Pokmon to use in battle and gain more Stardust to power up your Pokmon.

Please note, the event-exclusive Pokmon appearing in raids and in the wild will not occur in Japan, South Korea, and Italy. Event bonuses will still occur in Japan, South Korea, and Italy.

Date and time:

Strong Pokmon will be appearing in raids, including Skarmory, Swampert, Shieldon, and more! Registeel and Cresselia will be appearing in five-star raids. Youll also earn twice the usual Stardust from Raid Battles and Trainer Battles during this event. Please note that this bonus will not apply to GO Battle League Trainer Battles.

Featured Pokmon:

Date and time:

More Pokmon thought to be powerful in the GO Battle League will be available in raids, including Altered Forme Giratina in five-star raids. Fighting-type Pokmon will also be appearing more frequently in the wild! Also if youre lucky, you might find a Shiny Timburr! Your best bet would be battling and catching it in one-star raids!

There will also be the following GO Battle League bonuses during the event period.

Featured Pokmon

Niantic is tuning and tweaking several aspects of the GO Battle League. Were excited to announce the following changes to the GO Battle League for Season 1:

Season 1 will rotate through leagues, just like the preseason did. Season 2 is set to begin in early May, but please note that all these dates are still tentative. Stay tunedwell update you as soon as anything changes.

Original post:

GO Battle League Season 1: Everything You Need to Know - Pokemon GO Hub

What a joyous day for the Pokemon GO fans. It has been announced that Elite TMs are finally coming to the popular mobile game. It looks like these TMs will give the Trainers an ability to select which move they want their favorite Pokemon to learn and make them unstoppable.

In the first season of the Battle League, only single Elite TMs will be available. This is something we have already known for a long time, thanks to the data miners, which said that this item will let Trainers pick a movie from a selected list.

Now, with the official announcement we learned that the new item will let the players teach their Pokemon exclusive moves, including Community Day moves and also Raid exclusive moves. Woohoo! It was also stated that this is a rare item, which could only be obtained through Go Battle League.Because Niantic loves to listen to their fans, now we can see our Mewtwo, Zapdos and many other Legendary Pokemon meet their full potential.

The Elite TMs is that it will be an end of season reward for the first PvP season.

For last, heres how to use your Elite TMs, thanks to the following analysis and djf881.

How to use your elite TMs from r/TheSilphRoad

More here:

Pokemon Go Elite TMs and How to Get the Best Use out of Them - Future Game Releases

Acquire Market research furnishes the latest report on the TMS(Transcranial Magnetic Stimulation) Coil market Analysis and Forecast 2020-2025, outlining key insights and presenting a competitive advantage to clients through a comprehensive report. This report analyses the TMS(Transcranial Magnetic Stimulation) Coils industry coverage, current market competitive status, and market outlook. Global TMS(Transcranial Magnetic Stimulation) Coil players, to describe, define and analyze the value, market competition landscape, market share, SWOT analysis, and development plans in the future comprise some of the key features, in the report.

Global TMS(Transcranial Magnetic Stimulation) Coil Market Research Report compiles the latest industry data, key players analysis, market share, growth rate, opportunities and trends, investment strategy for your reference in analyzing the global market. Many companies are operating in the market and overseeing their businesses through joint ventures, which is likely to benefit the overall market.

Click Here To Access The Sample Report with Latest Industry Trends: https://www.acquiremarketresearch.com/sample-request/331541/

This report includes the following manufacturers: MAG & More, Magstim, MagVenture, ANT Neuro, Brain Latam Co, Deymed

Global TMS(Transcranial Magnetic Stimulation) Coil Market by Type Segment H-coil, C-core Coil, Circular Crown Coil

Global TMS(Transcranial Magnetic Stimulation) Coil Market Applications: Hospital, Clinic, Others

Get Reasonable Discount on this Premium Report: https://www.acquiremarketresearch.com/discount-request/331541/

Report Highlights:1) Detail pricing analysis on the basis of product, application, and regional segments2) The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global TMS(Transcranial Magnetic Stimulation) Coil Market3) Deep insights about regulatory and investment scenarios of the global TMS(Transcranial Magnetic Stimulation) Coil Market4) Analysis of market effect factors and their impact on the forecast and outlook of the global TMS(Transcranial Magnetic Stimulation) Coil Market5) A roadmap of growth opportunities available in the global TMS(Transcranial Magnetic Stimulation) Coil Market with the identification of key factors6) The exhaustive analysis of various trends of the global TMS(Transcranial Magnetic Stimulation) Coil Market to help identify market expansions

TMS(Transcranial Magnetic Stimulation) Coil Market by Region Segmentation: North America Country (United States, Canada)Asia Country (China, Japan, India, Korea)Europe Country (Germany, UK, France, Italy)Other Country (Middle East, Africa, GCC)

Benefits of Purchasing TMS(Transcranial Magnetic Stimulation) Coil Market Report: Analyst Support: Get your query resolved from our expert analysts before and after purchasing the report. Customers Satisfaction: Our expert team will assist with all your research needs and customize the report. Inimitable Expertise: Analysts will provide deep insights into the reports. Assured Quality: We focus on the quality and accuracy of the report.

The global TMS(Transcranial Magnetic Stimulation) Coil market size is expected to gain huge market traction in the forecast period of 2020 to 2025. The TMS(Transcranial Magnetic Stimulation) Coil market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players. Regional analysis is another highly comprehensive part of the research and analysis segment of the global TMS(Transcranial Magnetic Stimulation) Coil market presented in the report. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Interested in purchasing this Report? Click here: https://www.acquiremarketresearch.com/buy-now/331541/?price=su

Request a customized copy of TMS(Transcranial Magnetic Stimulation) Coil reportIf you wish to find more details of the report or want customization, contact us. You can get a detailed overview of the entire research here. If you have any special requirements, please let us know and we will customize the report as you want.

The report segments the market into various sub-segments, thereby encompassing the overall market. The approximations of the revenue numbers for the entire market and its sub-segments are also additionally incorporated in this report. Moreover, the report highlights some of the major growth prospects, including new product launches, M&A, R&D, collaborations, joint ventures, agreements, partnerships, and growth of the key players operating in the TMS(Transcranial Magnetic Stimulation) Coil market. It determines the factors that are directly influencing the market which comprises production strategies and methodologies, development platforms, and the product model.

About us:

Acquire Market Research is a market research-based company empowering companies with data-driven insights. We provide Market Research Reports with accurate and well-informed data, Real-Time with Real Application. A good research methodology proves to be powerful and simplified information that applied right from day-to-day lives to complex decisions helps us navigate through with vision, purpose and well-armed strategies. At Acquire Market Research, we constantly strive for innovation in the techniques and the quality of analysis that goes into our reports.

Contact Us:

Sally Mach555 Madison Avenue,5th Floor, Manhattan,New York, 10022 USAPhone No: +1 (800) 663-5579Email ID: [emailprotected]

Excerpt from:

Massive growth of Preservation TMS(Transcranial Magnetic Stimulation) Coil Market 2025 with high CAGR In Coming Years with Focusing Key players like...

BETHEL In late February, Telstar Middle School Dean of Students, Lindsay Luetje, was the recipient of New England League of Middle Schools (NELMS) A+ Administrator Award. She was one of three administrators to be recognized.

Luetje, described by peers as passionate, empathetic and a champion, acts as the schools energizer bunny, whose efforts inside and outside its doors never seem to end.

After teaching eighth grade English/Language Arts for 20 years at Telstar, Luetje was named Dean of TMS Students in 2018. The decision to transition into an administrative role was not easy for Luetje, considering her love for teaching.

Teacher Stephanie Mastroianni submitted a letter to the NELMS, nominating Luetje for the award. The choice was an easy one for her.

Lindsay is a powerhouse, who, as our dean of students, leads the TMS faculty and students with determination, sensitivity and boundless energy, Mastroianni said in her letter.

Superintendent Dave Murphy also spoke on Luetjes value to the school.

This award is well-deserved recognition for an outstanding educator. As the Dean of Telstar Middle School, Lindsay Luetje has been able to effectively build on the relationships she first developed with students, parents and staff during her years as an exemplary classroom teacher in the school, Murphy said. Her level of investment in her students and staff is apparent to all who come in contact with her. Her nomination and ultimate selection for this award is acknowledgement of her many efforts. She is a true champion of her school and has excelled in her role as Dean of Students. We are fortunate to have her as part of the MSAD 44 team.

She is a vital part of the team indeed. Another part of her job is resolving conflicts. Both students and faculty have approached her for help, and sometimes resulting in restorative circles. Mastroianni explained the purpose of the circle is to have the person/people who inflicted harm and the person/people who were harmed come together and talk. The person who was upset has the chance to speak about why they were upset, while the other person listens. Then the person who caused the distress has the opportunity to respond.

Often in these situations Luetje is usually asked by faculty or students for help, simply because they trust her, Mastroianni said. She added that Luetjes well-balanced demeanor plays to her advantage, being able to display empathy and sympathy toward students, but also putting her foot down when they are misbehaving.

Some mornings, students witness Luetjes fun side. The last school day of each month shell play music to kick off Telstars Star Assembly Days, a school-wide assembly that occurs at the end of each month that focuses on topics like perseverance, embracing failure, and building healthy friendships, the latter of which was the most recent topic. Sometimes Luetje will also play music if she feels the school needs a pick-me-up after a rough week.

This past Valentines Day, she took heart cutouts and put pencils in each of them. Staying after hours once again, Luetje went to every locker in the school and taped the cutout on them with the words you matter on them. She wrote personal notes to teachers and stuck them on their doors.

Although her title says Dean of Students, she looks after faculty, too. On difficult days, and even weeks, Luetje will make tea for staff members and has made a crock pot of soup for them to share also.

Luetje volunteers for bus duty, lunch duty and detention duty. When a good portion of school was hit by an illness, Luetje, along with students, helped clean sections of the school because the maintenance crew was short staffed. She also substituted many classes until teachers returned.

One of Luetjes biggest involvements is with the Oxford County Resiliency Project, a group that has tried to reduce the effects Adverse Childhood Experiences (A.C.E.S.) has had on children. Mastroianni noted in her letter that many students come from homes where A.C.E.S. occur frequently. Her work with the project sanctioned Telstar to get a two-year grant worth more than $200,000. The goal of the grant is to develop and sustain a trauma responsive school system.

She is also known for her ability to work with parents.

Ive sat in and taken notes on her phone conversations with parents, Mastroianni said.

Luetje listens to parents perspectives and shares her own with them, using her well-balanced demeanor to ease a tense conversation, if needed.

Her efforts do not stop outside Telstar. She coaches soccer for kindergarteners, takes students out after hours for bowling and movie nights and started a remembrance garden to honor students and staff that have died. Over the past three years, thanks to volunteers, students and donations, more than 1,500 bulbs have been planted.

Last summer she helped provide the best possible experience for Chinese students who traveled to Bethel as part of a program put together by her, Dean of THS Students John Eliot, and other staff. During the Chinese students stay, Luetje planned activities, gave a writing lesson and hosted the entire group at her house for table painting, blueberry picking and bonfire smores. In November, she and Eliot traveled to China with four students for two weeks, where they visited multiple schools, toured Beijing City and visited the Great Wall.

According to Mastroianni, Luetje arrives around 7 a.m. and leaves by 5:30 p.m. at the earliest. Often though, shell stay later. In that window of time she not only carries the weight of being dean to 159 enrolled students, but also still manages to teach one period of public speaking a day to eighth graders. When she is home, she has five-year-old twins waiting for her. Thats a lot to have on one plate, but yet, her energy still seems endless.

I appreciate the recognition for my efforts, but honestly, I dont do this job for awards. I really love what I do middle school kids are my jam, Luetje said.

Invalid username/password.

Please check your email to confirm and complete your registration.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.

Previous

Next

Read this article:

Lindsay Luetje goes above and beyond as Telstar dean - Lewiston Sun Journal

The following blog post, unless otherwise noted, was written by a member of Gamasutras community.The thoughts and opinions expressed are those of the writer and not Gamasutra or its parent company.

This blog is originally published on LocalizeDirect website.

What is Localization CMS?

Agame localization CMSis an all-in-one localization system that handles every aspect of your game translation. Its a collaborative platform that gives everyone concerned a real-time view of precisely where your localization efforts are.

Developers, translation teams, and testers can all use the localization CMS wherever they are based. It acts as a central repository for game assets from text strings to audio files to images. Its a complete game localization system that allows text strings and queries to be shared, tracks changes, and controls access to source and translated text.

It makes life easier for everyone

Atranslation management system (TMS) can also act as a localization platform and covers some of the same bases as a CMS. A TMS helps you manage translations, assign tasks, and may offer translation memory and machine translation. Like any good game localization tool, it will also offer reports on progress.

You may be wondering what the difference between CMS and TMS is - a game localization CMS can go beyond simple translation to help developers with the organization of game assets and the management of game quality. A localization CMS offers a deeper tool set and greater transparency.

To truly appreciate the benefits of a game localization CMS, you must consider the traditional game development life cycle and the most commonly used tools for localization. Usually, game localizations occur at the very end of development in rushed batches. The most used game localization tool is probably the humble spreadsheet.

The trouble with spreadsheets

What happens when you start sharing a spreadsheet and coordinating departments via email? Mistakes happen. People use the wrong version and miss the latest string translations. People overwrite completed work accidentally or ask questions that have already been answered. Tasks that could be automated have to be completed manually. An import and export procedure must be worked out. If files are delayed and dont make the build in time, they must wait for the next one.

Its also a slow procedure. The developers send a spreadsheet to the translators who come back with questions before they can complete the translation. The first version is then loaded into the game and testers look and flag any issues. The developers must fix the issues, which may require a new translation, and so it goes.

Rinse and repeat

This back and forth is even more of an issue in the age of DLC and game expansions. A game may continue to grow for years after release and expand with a steady stream of content that all must be localized. With the traditional model, youre starting from scratch again every single time.

via GIPHY

With a game localization CMS you have a clear framework for the localization project and that offers many compelling advantages:

In short, a localization CMS allows you to build a solid foundation. But thats not all: Its also free of the typical issues that arise from copying and pasting into countless different versions of spreadsheets that are sent back and forth.

Every action is recorded

If there is an error, you can track it down, see who was responsible and roll back if necessary. You can control what goes into each version of the game. You can track and filter strings and apply translations across the board. Theres no need to redo work that has already been done, and the CMS ensures you dont miss anything that may need to be amended in an update or after a last-minute change.

You can start this process right from day one, theres no need to wait until the end of development this localization software is flexible and fully scalable.

Direct to game

With robust API integration you can even set your localization CMS to push strings directly into the game, enabling testers to tweak and fix things without having to disturb a programmer. You can also set simple limits based on character counts or pixel-based text limits, so overlong strings are flagged before they get into the game.

What once took a week of back and forth can potentially be achieved in a few minutes with a localization CMS.

Nothing is ever lost

Every string, every piece of information, every developer note, every translator question and clarification, and every change that has been made is there nothing is lost. If you need to track down a specific piece of text, you can use a filter search with regular expressions you can even layer multiple filters. All the valuable localization data you accumulate can be accessed and reused.

Game localizations done faster, cheaper, and better

A localization CMS enables you to localize your game much more quickly, reducing costs and helping you to eradicate mistakes in the process. Ultimately, it allows your talent to work closely together to craft high quality localizations that match your intentions, making your game the best possible experience for every player.

What functions should the best localization system have? Find an answer here >>>How To Choose The Right Localization CMS

Wondering what features should your perfect loc CMS have? >>>Check it in the 2nd part of the blog.

See original here:

What Is A Game Localization System And What Can It Do For You? [Part 1] - Gamasutra

PATTERSON, N.J., March 04, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay), a global leader in the advanced non-invasive treatment of brain disorders, today announced that Dr. Christopher von Jako, Chief Executive Officer, will participate in the upcoming investor conferences.

About BrainsWayBrainsWay is a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products using the Companys proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive compulsive disorder (OCD), for which BrainsWay received marketing authorization from the U.S. Food and Drug Administration (FDA) in 2013 (for MDD) and in August 2018 (for OCD). BrainsWay is currently conducting clinical trials of Deep TMS in other psychiatric, neurological and addiction disorders.

Forward-Looking StatementThis press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words intends, may, will, plans, expects, anticipates, projects, predicts, estimates, aims, believes, hopes, potential or similar words. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In addition, historical results or conclusions from scientific research and clinical studies do not guarantee that future results would suggest similar conclusions or that historical results referred to herein would be interpreted similarly in light of additional research or otherwise. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: inadequacy of financial resources to meet future capital requirements; changes in technology and market requirements; delays or obstacles in launching and/or successfully completing planned studies and clinical trials; failure to obtain approvals by regulatory agencies in the Companys anticipated timeframe, or at all; inability to retain or attract key employees whose knowledge is essential to the development of Deep TMS products; unforeseen difficulties with Deep TMS products and processes, and/or inability to develop necessary enhancements; unexpected costs related to Deep TMS products; failure to obtain and maintain adequate protection of the Companys intellectual property, including intellectual property licensed to the Company; the potential for product liability; changes in legislation and applicable rules and regulations; unfavorable market perception and acceptance of Deep TMS technology; inadequate or delays in reimbursement from third-party payers, including insurance companies and Medicare; inability to commercialize Deep TMS, including internationally, by the Company or through third-party distributors; product development by competitors; inability to timely develop and introduce new technologies, products and applications, which could cause the actual results or performance of the Company to differ materially from those contemplated in such forward-looking statements.

Any forward-looking statement in this press release speaks only as of the date of this press release. The Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws. More detailed information about the risks and uncertainties affecting the Company is contained under the heading Risk Factors in the Companys filings with the U.S. Securities and Exchange Commission.

Contacts: BrainsWay Ltd. Hadar Levy Chief Financial Officer hadarl@Brainsway.com

Bob YedidLifeSci Advisors646-597-6989Bob@LifeSciAdvisors.com

Read the rest here:

BrainsWay to Participate in Upcoming Investor Conferences - Yahoo Finance

Introducing new quality of translation project management! Space TMS storms the localisation industry with all guns blazing!

Its simple, its efficient, its reliable, its good-looking. And its cheap. The new translation management system for language service providers is here, and you should not miss it. Space TMS offers all the features your company needs to efficiently manage linguistic projects.

The aim of Space TMS is to improve the workflow at all company levels: owners, project managers and translators.

Lets start from the beginning. The owners and senior management can easily monitor how the company functions. They can gain access to each of the team members data on current tasks and their level of completion. If any data or statistics are promptly needed, e.g. to be presented at a meeting or a conference, they are easily accessible.

Space TMS is a great tool that originated from LSPs needs, says Alex Chudy, director of Space TMS LTD. Every module and every feature is the result of common work of project managers, vendor managers, owners, translators and other service providers involved on a daily basis in a translation process.

Secondly, a well-designed TMS covers the needs of project managers. Via Space TMS, they can easily set up tasks, assign them to specific vendors, with whom they can keep in close touch, as well as monitor and evaluate their work.

This short instructional video shows it all!

Last but not least, Space TMS is useful for translators.

Language experts can set up their preferences and accept jobs. This gives them freedom and flexibility as well as opportunity to choose the tasks they specialise in.

Space TMS will gain popularity among LSPs thanks to its simplicity, low cost and multi-functionality. Improved communication and translation project workflow will create space for new customers, sums up Chudy.

Yes, the cost is also very important, and in the case of Space TMS, it is inversely proportional to the efficiency. Being one of the cheapest solutions on the market, it is a system for big and small players in the language industry.

Our product is licensed and delivered in a SaaS model (software as a service). The work in a cloud-based environment is fast and easy, there is no need to worry about the performance of particular computers in the office. You simply log in and start working. No distractions, no problems.

As Alex Chudy admits, the launch is just the beginning, since Space TMS is changing almost every day. It will continue to grow and become more and more flexible for the sake of its users.

Check out the system that is out of this world!

Projects, tasks, client and translator bases, invoices, statistics always at hand from anywhere on Earth and beyond!

Original post:

Make Your Workflow Smooth and Effective! This New System is the Key - Slator